Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Aritrick Chatterjee

TitleResearch Assistant Professor
InstitutionUniversity of Chicago
DepartmentRadiology-Basic Sciences
AddressChicago IL 60637
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California San Diego, USABS6/2010Bioengineering
    University College London, London, UKMSc9/2011Physics and Engineering in Medicine
    University of Sydney, Sydney, AustraliaPhD6/2016Health Science (MRI)
    University of Chicago, Chicago, IL, USAPostdoctoral Training1/2019Prostate MRI

    Collapse Research 
    Collapse research activities and funding
    Industry funding     (Aytekin Oto)Jun 1, 2018 - May 30, 2020
    Guerbet LLC
    Development and testing of Split Dose Dotarem with DCE-MRI for Diagnosis of Prostate Cancer
    Role: Co-Investigator

    RSNA Education Scholar Grant (ESCH1805)     (Aritrick Chatterjee)Jul 1, 2018 - Jun 30, 2020
    Radiological Society of North America (RSNA)
    An Interactive App with Multi-parametric MRI - Whole Mount Histology Correlation for Enhanced Prostate MRI Training of Radiologists
    Role: Principal Investigator

    1R01CA228036-01A1     (OTO, AYTEKIN)Apr 3, 2019 - Mar 31, 2024
    NIH
    Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI
    Role: Co-Investigator

    Departmental Research Seed Funding     (Aritrick Chatterjee)Jul 1, 2019 - Jun 30, 2020
    Departmental of Radiology, University of Chicago
    MR based quantitative analysis and tissue composition measures in high risk population for prostate cancer: Racial discrepancies and impact on cancer detection
    Role: Principal Investigator

    R41CA244056     (OTO, AYTEKIN)Apr 1, 2020 - Mar 31, 2021
    NIH
    MR Virtual Pathology of the Prostate
    Role: Co-Investigator

    CDAC Discovery Grant     (Aritrick Chatterjee)May 1, 2020 - Apr 30, 2021
    University of Chicago Center for Data and Computing (CDAC) (Chicago)
    Automated Prostate Cancer Detection using Hybrid Multi-dimensional MRI and Deep Learning
    Role Description: Apply deep learning methods to cutting-edge medical imaging to improve the diagnostic accuracy of detecting prostate cancer.
    Role: Principal Investigator

    UCHAP Prostate Cancer Pilot Project Award     (Aritrick Chatterjee)Mar 1, 2021 - Feb 28, 2022
    UCHAP
    MR based quantitative analysis and tissue composition measures in high risk population for prostate cancer: Racial disparities and impact on cancer detection
    Role: Principal Investigator

    CDAC 2021 Discovery Challenge     (Chenhao Tan)Mar 1, 2021 - Feb 28, 2023
    University of Chicago Center for Data and Computing (CDAC)
    AI-Driven Tutorials for Radiology Student Training
    Role: Co-Investigator

    2UT2CA244056     (Aytekin Oto, Gregory S Karczmar, Aritrick Chatterjee, Xiaobing Fan)Jul 1, 2022 - Jun 30, 2024
    NIH/ NCI
    MRI Virtual Pathology of the Prostate: Multi-center multi-vendor application and validation
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lee GH, Chatterjee A, Karademir I, Engelmann R, Yousuf A, Giurcanu M, Harmath CB, Karczmar GS, Oto A. Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI. Radiology. 2022 Jul 26; 211895. PMID: 35880981.
      View in: PubMed
    2. Gundogdu B, Pittman JM, Chatterjee A, Szasz T, Lee G, Giurcanu M, Medved M, Engelmann R, Guo X, Yousuf A, Antic T, Devaraj A, Fan X, Oto A, Karczmar GS. Directional and inter-acquisition variability in diffusion-weighted imaging and editing for restricted diffusion. Magn Reson Med. 2022 11; 88(5):2298-2310. PMID: 35861268.
      View in: PubMed
    3. Szasz T, Lee G, Chatterjee A, Medved M, Devaraj A, Yousuf A, Fan X, Karczmar GS, Oto A. Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging. Abdom Radiol (NY). 2022 07; 47(7):2500-2508. PMID: 35583823.
      View in: PubMed
    4. Chatterjee A, Oto A. Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI. Radiology. 2022 06; 303(3):588-589. PMID: 35258378.
      View in: PubMed
    5. Chatterjee A, Antic T, Gallan AJ, Paner GP, Lin LI, Karczmar GS, Oto A. Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures. Abdom Radiol (NY). 2022 02; 47(2):801-813. PMID: 34878579.
      View in: PubMed
    6. Chatterjee A, Mercado C, Bourne RM, Yousuf A, Hess B, Antic T, Eggener S, Oto A, Karczmar GS. Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings. Radiology. 2022 02; 302(2):368-377. PMID: 34751615.
      View in: PubMed
    7. Chatterjee A, Turchan WT, Fan X, Griffin A, Yousuf A, Karczmar GS, Liauw SL, Oto A. Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer? Acad Radiol. 2022 07; 29(7):977-985. PMID: 34645572.
      View in: PubMed
    8. Fan X, Chatterjee A, Pittman JM, Yousuf A, Antic T, Karczmar GS, Oto A. Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer. Acad Radiol. 2022 06; 29(6):796-803. PMID: 34583866.
      View in: PubMed
    9. Medved M, Chatterjee A, Devaraj A, Harmath C, Lee G, Yousuf A, Antic T, Oto A, Karczmar GS. High spectral and spatial resolution MRI of prostate cancer: a pilot study. Magn Reson Med. 2021 09; 86(3):1505-1513. PMID: 33963782.
      View in: PubMed
    10. Fan X, Chatterjee A, Medved M, Oto A, Karczmar GS. Signal intensity form of the Tofts model for quantitative analysis of prostate dynamic contrast enhanced MRI data. Phys Med Biol. 2021 01 22; 66(2):025002. PMID: 33181487.
      View in: PubMed
    11. Chatterjee A, Harmath C, Oto A. New prostate MRI techniques and sequences. Abdom Radiol (NY). 2020 12; 45(12):4052-4062. PMID: 32248259.
      View in: PubMed
    12. Sun C, Wang S, Chatterjee A, Medved M, Eggener S, Karczmar GS, Oto A. T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy. Eur Radiol. 2021 Jan; 31(1):325-332. PMID: 32785769.
      View in: PubMed
    13. Chatterjee A, Thomas S, Oto A. Prostate MR: pitfalls and benign lesions. Abdom Radiol (NY). 2020 07; 45(7):2154-2164. PMID: 31705249.
      View in: PubMed
    14. Aritrick Chatterjee, Federico Pineda, Gregory S. Karczmar, Aytekin Oto. Prostate MRI Essentials, (Editor- T. Tirkes). Dynamic Contrast-Enhanced Imaging. 2020; 75-87.
    15. Chatterjee A, Nolan P, Sun C, Mathew M, Dwivedi D, Yousuf A, Antic T, Karczmar GS, Oto A. Effect of Echo Times on Prostate Cancer Detection on T2-Weighted Images. Acad Radiol. 2020 11; 27(11):1555-1563. PMID: 31992480.
      View in: PubMed
    16. Chatterjee A, Sun C, Oto A. Reply to "Prostate Cancer Index Lesion Detection and Volume Estimation: Is Dynamic Contrast-Enhanced MRI Really Reliable?" AJR Am J Roentgenol. 2019 12; 213(6):W290. PMID: 31755764.
      View in: PubMed
    17. He D, Fan X, Chatterjee A, Wang S, Medved M, Pineda FD, Yousuf A, Antic T, Oto A, Karczmar GS. A compact solution for estimation of physiological parameters from ultrafast prostate dynamic contrast enhanced MRI. Phys Med Biol. 2019 08 07; 64(15):155012. PMID: 31220816.
      View in: PubMed
    18. Chatterjee A, Gallan AJ, He D, Fan X, Mustafi D, Yousuf A, Antic T, Karczmar GS, Oto A. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. Abdom Radiol (NY). 2019 06; 44(6):2233-2243. PMID: 30955071.
      View in: PubMed
    19. Chatterjee A, He D, Fan X, Antic T, Jiang Y, Eggener S, Karczmar GS, Oto A. Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study. AJR Am J Roentgenol. 2019 08; 213(2):W66-W75. PMID: 31039019.
      View in: PubMed
    20. Chatterjee A, Oto A. Future Perspectives in Multiparametric Prostate MR Imaging. Magn Reson Imaging Clin N Am. 2019 Feb; 27(1):117-130. PMID: 30466906.
      View in: PubMed
    21. Sun C, Chatterjee A, Yousuf A, Antic T, Eggener S, Karczmar GS, Oto A. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology. AJR Am J Roentgenol. 2019 02; 212(2):351-356. PMID: 30540213.
      View in: PubMed
    22. Knull E, Oto A, Eggener S, Tessier D, Guneyli S, Chatterjee A, Fenster A. Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy. Med Phys. 2019 Feb; 46(2):800-810. PMID: 30447155.
      View in: PubMed
    23. Chatterjee A, Tokdemir S, Gallan AJ, Yousuf A, Antic T, Karczmar GS, Oto A. Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate. AJR Am J Roentgenol. 2019 01; 212(1):124-129. PMID: 30403532.
      View in: PubMed
    24. He D, Chatterjee A, Fan X, Wang S, Eggener S, Yousuf A, Antic T, Oto A, Karczmar GS. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis. Invest Radiol. 2018 10; 53(10):609-615. PMID: 29702525.
      View in: PubMed
    25. Westin C, Chatterjee A, Ku E, Yousuf A, Wang S, Thomas S, Fan X, Eggener S, Karczmar G, Oto A. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer. AJR Am J Roentgenol. 2018 09; 211(3):595-604. PMID: 29995499.
      View in: PubMed
    26. Chatterjee A, Devaraj A, Mathew M, Szasz T, Antic T, Karczmar GS, Oto A. Performance of T2 Maps in the Detection of Prostate Cancer. Acad Radiol. 2019 01; 26(1):15-21. PMID: 29731420.
      View in: PubMed
    27. Chatterjee A, Bourne RM, Wang S, Devaraj A, Gallan AJ, Antic T, Karczmar GS, Oto A. Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study. Radiology. 2018 06; 287(3):864-873. PMID: 29393821.
      View in: PubMed
    28. Chatterjee A, He D, Fan X, Wang S, Szasz T, Yousuf A, Pineda F, Antic T, Mathew M, Karczmar GS, Oto A. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer. Acad Radiol. 2018 03; 25(3):349-358. PMID: 29167070.
      View in: PubMed
    29. Bourne RM, Bongers A, Chatterjee A, Sved P, Watson G. Diffusion anisotropy in fresh and fixed prostate tissue ex vivo. Magn Reson Med. 2016 08; 76(2):626-34. PMID: 26445008.
      View in: PubMed
    30. Chatterjee A, Watson G, Myint E, Sved P, McEntee M, Bourne R. Changes in Epithelium, Stroma, and Lumen Space Correlate More Strongly with Gleason Pattern and Are Stronger Predictors of Prostate ADC Changes than Cellularity Metrics. Radiology. 2015 Dec; 277(3):751-62. PMID: 26110669.
      View in: PubMed
    31. Siow B, Drobnjak I, Chatterjee A, Lythgoe MF, Alexander DC. Estimation of pore size in a microstructure phantom using the optimised gradient waveform diffusion weighted NMR sequence. J Magn Reson. 2012 Jan; 214(1):51-60. PMID: 22116034.
      View in: PubMed
    Chatterjee's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _